Partnership Forum Opportunities

Collaborate. Network. Optimize.

Live and interactive, AMCP Partnership Forums bring together key decision-makers in managed care, integrated care networks, the pharmaceutical industry, and other vital sectors to discuss and collaborate on strategies to drive efficiency and improve patient outcomes. Designed to address current market challenges and opportunities, AMCP Partnership Forums also: 

  • Take a proactive, collaborative approach to solving critical issues and challenges. 
  • Gain consensus on challenges or opportunities to remove barriers to improve patient care and optimize value for all stakeholders. 
  • Represent opportunities for payers, manufacturers, patients, and other stakeholders to work together on common goals and interests and create actionable results. 
  • Experience high visibility among industry stakeholders and policymakers. 

Sponsor a Partnership Forum

Position your company as a leader in championing value and access in pursuit of innovative strategies to connect patients with the medication they need at a cost they can afford. Sponsorship of a partnership forum empowers your company to drive conversations that will establish the vision for a new era in health care.

In addition to this benefit, working with AMCP exposes you to our:

  • Growing membership base of 7,000.
  • Members who influence the health care coverage of the nearly 300 million served by private/public health plans, PBMs, and emerging care models.
  • Members who work for 22 of the top 25 health plans in the U.S.

Contact @email to discuss sponsorships.

Recent Partnership Forums

Patient Input and Payer Decision-Making

Dec. 6–7, 2023 | Old Town Alexandria, VA

There has been growing consensus in recent years for health care to become more “‘patient-centric” by including consideration of patient preferences, needs, and values in clinical decision-making. Some examples include the Food and Drug Administration’s patient-focused drug development program, quality measures that increasingly include patient-reported outcome measures, and providers and patients using shared-decision making tools to discuss treatment options. To assess population health decisions, particularly in managed care pharmacy, there have been increasing calls for scientifically generated patient information to supplement existing evidence for the assessment of value and coverage decisions with outcomes that matter to patients. In both the US and globally, there are health technology assessment groups that engage patients when assessing value. In addition, many US states require patients to be included in their Medicaid DUR boards. This Partnership Forum will serve to initiate a discussion about the development of a framework for health plans/payers to engage patient advocacy organizations in managed care pharmacy decision-making.

This Partnership Forum will seek to identify the value of collaboration between health plans/payers and patient advocacy organizations in managed care pharmacy decision-making. Participants will discuss barriers and potential solutions to collaboration and provide insight into tools that have been developed to optimize partnerships across organizations.

Previous Partnership Forums
 


Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement

August 30–31, 2022| Renaissance Arlington Capital View Hotel

In the transition from paying for the volume of health care to paying for value, health technology assessment (HTA) and value framework tools can serve as a resource for determining value of pharmaceuticals and other health interventions. Publicly available frameworks can provide valuable insights for health plans and PBMs as they evaluate appropriate use, coverage, and reimbursement for treatments. However, these tools must be based on sound methods using good scientific evidence and economic models, consider the totality of the evidence, incorporate the views of patients, and align value across stakeholders.

This Partnership Forum identified opportunities to improve how value assessments are developed and applied to formulary decision-making and provide strategies and guidance on best practices to equip managed care pharmacists and other professionals when applying these tools to assess value and optimize patient care.